These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 18936974)

  • 41. Significance of AEG-1 expression in correlation with VEGF, microvessel density and clinicopathological characteristics in triple-negative breast cancer.
    Li C; Li R; Song H; Wang D; Feng T; Yu X; Zhao Y; Liu J; Yu X; Wang Y; Geng J
    J Surg Oncol; 2011 Feb; 103(2):184-92. PubMed ID: 21259255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Labeling of microvessel density, lymphatic vessel density and potential role of proangiogenic and lymphangiogenic factors as a predictive/prognostic factors after radiotherapy in patients with cervical cancer.
    Biedka M; Makarewicz R; Marszałek A; Sir J; Kardymowicz H; Goralewska A
    Eur J Gynaecol Oncol; 2012; 33(4):399-405. PubMed ID: 23091898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of vascular endothelial growth factor expression to overall survival in feline invasive mammary carcinomas.
    Millanta F; Lazzeri G; Vannozzi I; Viacava P; Poli A
    Vet Pathol; 2002 Nov; 39(6):690-6. PubMed ID: 12450199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The relationship between vascular endothelial growth factor, microvascular density, lymph node metastasis and prognosis of breast carcinoma].
    Wang F; Wei L; Chen L
    Zhonghua Bing Li Xue Za Zhi; 2000 Jun; 29(3):172-5. PubMed ID: 11866906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Necrosis degree displayed in computed tomography images correlated with hypoxia and angiogenesis in breast cancer.
    Shan X; Wang D; Chen J; Xiao X; Jiang Y; Wang Y; Fan Y
    J Comput Assist Tomogr; 2013; 37(1):22-8. PubMed ID: 23321829
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantifying tumour vascularity in non-luminal breast cancers.
    Kraby MR; Opdahl S; Akslen LA; Bofin AM
    J Clin Pathol; 2017 Sep; 70(9):766-774. PubMed ID: 28249942
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive and prognostic angiogenic markers in a gynecologic oncology group phase II trial of bevacizumab in recurrent and persistent ovarian or peritoneal cancer.
    Han ES; Burger RA; Darcy KM; Sill MW; Randall LM; Chase D; Parmakhtiar B; Monk BJ; Greer BE; Connelly P; Degeest K; Fruehauf JP
    Gynecol Oncol; 2010 Dec; 119(3):484-90. PubMed ID: 20870280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of protein pigment epithelium-derived factor (PEDF) and microvessel density (MVD) as prognostic indicators in breast cancer.
    Zhou D; Cheng SQ; Ji HF; Wang JS; Xu HT; Zhang GQ; Pang D
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1719-27. PubMed ID: 20229034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma.
    Abdulrauf SI; Edvardsen K; Ho KL; Yang XY; Rock JP; Rosenblum ML
    J Neurosurg; 1998 Mar; 88(3):513-20. PubMed ID: 9488306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum vascular endothelial growth factor and angiogenesis are related to the prognosis of patients with gastrointestinal stromal tumors.
    Wang TB; Qiu WS; Wei B; Deng MH; Wei HB; Dong WG
    Ir J Med Sci; 2009 Sep; 178(3):315-20. PubMed ID: 19367428
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.
    Bremnes RM; Camps C; Sirera R
    Lung Cancer; 2006 Feb; 51(2):143-58. PubMed ID: 16360975
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.
    Marotta V; Sciammarella C; Capasso M; Testori A; Pivonello C; Chiofalo MG; Gambardella C; Grasso M; Antonino A; Annunziata A; Macchia PE; Pivonello R; Santini L; Botti G; Losito S; Pezzullo L; Colao A; Faggiano A
    J Clin Endocrinol Metab; 2017 Feb; 102(2):661-671. PubMed ID: 27849428
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome.
    Barresi V; Di Gregorio C; Regiani-Bonetti L; Ponz-De Leon M; Barresi G; Vitarelli E
    Virchows Arch; 2010 Jul; 457(1):11-9. PubMed ID: 20532559
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Expression of vascular endothelial growth factor in different breast tissues and clinical significance thereof].
    Xu WG; Wang G; Liu Y; Zou YH; Song JN; Yang XQ; Wang WY
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):802-4. PubMed ID: 18756980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
    Adams J; Carder PJ; Downey S; Forbes MA; MacLennan K; Allgar V; Kaufman S; Hallam S; Bicknell R; Walker JJ; Cairnduff F; Selby PJ; Perren TJ; Lansdown M; Banks RE
    Cancer Res; 2000 Jun; 60(11):2898-905. PubMed ID: 10850435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum vascular endothelial growth factor (VEGF) levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer.
    Iovino F; Ferraraccio F; Orditura M; Antoniol G; Morgillo F; Cascone T; Diadema MR; Aurilio G; Santabarbara G; Ruggiero R; Belli C; Irlandese E; Fasano M; Ciardiello F; Procaccini E; Lo Schiavo F; Catalano G; De Vita F
    Cancer Invest; 2008; 26(3):250-5. PubMed ID: 18317965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CT contrast enhancement correlates with pathological grade and microvessel density of pancreatic cancer tissues.
    Wang SH; Sun YF; Liu Y; Zhou Y; Liu Y
    Int J Clin Exp Pathol; 2015; 8(5):5443-9. PubMed ID: 26191248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microvessel density (MVD) and vascular endothelial growth factor expression (VEGF) in human oral squamous cell carcinoma.
    Artese L; Rubini C; Ferrero G; Fioroni M; Santinelli A; Piattelli A
    Anticancer Res; 2001; 21(1B):689-95. PubMed ID: 11299827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D.
    Miyata Y; Kanda S; Ohba K; Nomata K; Hayashida Y; Eguchi J; Hayashi T; Kanetake H
    Clin Cancer Res; 2006 Feb; 12(3 Pt 1):800-6. PubMed ID: 16467091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
    Shang ZJ; Li JR
    J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.